Institutional Ownership
Fortress Biotech Inc
CUSIP 34960Q307COM NEWFBIOQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
18.4%
Max % of class reported
Institutional Holders
48
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Oct 25, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 25, 2024 | Highbridge Capital Management LLC | 13G | 9.0% | 2.73M | SEC |
| 2 | Sep 25, 2024 | Rosenwald Lindsay A Md | 13D/A | 18.4% | 5.22M | SEC |
| 3 | Jan 3, 2024 | Rosenwald Lindsay A Md | 13D/A | 15.3% | 2.81M | SEC |
| 4 | Nov 21, 2023 | Weiss Michael S | 13D/A | 7.6% | 1.13M | SEC |
| 5 | Nov 21, 2023 | Rosenwald Lindsay A Md | 13D/A | 17.5% | 2.60M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Opaleye Management Inc. | 1.04M | $2.91M |
| 2 | Geode Capital Management, LLC | 290.3K | $810.1K |
| 3 | Northern Trust Corp | 230.1K | $641.8K |
| 4 | Susquehanna International Group, LLP | 210.7K | $588.0K |
| 5 | Blackrock, Inc. | 197.1K | $549.9K |
| 6 | Two Sigma Investments, LP | 196.8K | $549.1K |
| 7 | Bridgeway Capital Management, LLC | 182.4K | $508.8K |
| 8 | Citadel Advisors LLC | 180.3K | $503.0K |
| 9 | Kestra Advisory Services, LLC | 129.8K | $362.1K |
| 10 | Hb Wealth Management, LLC | 120.2K | $335.3K |